Literature DB >> 16886625

The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue.

Alexandros Lekas1, Andreas C Lazaris, Charalampos Deliveliotis, Michail Chrisofos, Christina Zoubouli, Dimitrios Lapas, Thomas Papathomas, Ioannis Fokitis, Lydia Nakopoulou.   

Abstract

BACKGROUND: The process of ingrowth of new blood vessels is stimulated by the action of vascular endothelial growth factor (VEGF), while it may be simultaneously related to the degree of tissue hypoxia. Hypoxia-inducible factor 1alpha (HIF-1alpha) is a protein of cellular response to hypoxia. The relationship between hypoxia and angiogenesis in patients with benign prostate hyperplasia (BPH) and prostate cancer (PCa) was examined.
MATERIALS AND METHODS: One hundred and seventy (170) prostatic tissue samples were immunohistochemically evaluated. The microvessel density (MVD) was calculated by CD34 immunostaining; the angiogenetic profile was further assessed using a monoclonal antibody against VEGF. HIF-1alpha immunoreaction was recognized through nuclear staining of positive cells.
RESULTS: CD34, VEGF and HIF-1alpha staining reactions were significantly higher in the PCa group than in the BPH group. In both groups, an interrelationship between the immunoexpression of CD34 and HIF-1alpha, VEGF and HIF-1alpha, as well as VEGF and CD34 was detected.
CONCLUSION: MVD, VEGF cytoplasmic immunoreactivity and HIF-1alpha immunoreaction were more prominent in PCa than in BPH and were also significantly associated with high-grade carcinomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886625

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.

Authors:  Rita Garcia-Parra; David Wood; Rajal B Shah; Javed Siddiqui; Hero Hussain; Hyunjin Park; Timothy Desmond; Charles Meyer; Morand Piert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-16       Impact factor: 9.236

2.  Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study.

Authors:  Erin L Van Blarigan; John P Gerstenberger; June M Chan; Lorelei A Mucci; Stacey A Kenfield; Edward L Giovannucci; Meir J Stampfer; Lee W Jones; Steven K Clinton
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

Review 3.  Hypoxia, notch signalling, and prostate cancer.

Authors:  Laure Marignol; Karla Rivera-Figueroa; Thomas Lynch; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

4.  Digoxin inhibits blood vessel density and HIF-1a expression in castration-resistant C4-2 xenograft prostate tumors.

Authors:  Bishoy A Gayed; Katherine J O'Malley; Jan Pilch; Zhou Wang
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

5.  SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.

Authors:  Tasneem Bawa-Khalfe; Jinke Cheng; Sue-Hwa Lin; Michael M Ittmann; Edward T H Yeh
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

6.  Morphoproteomic confirmation of a constitutively activated mTOR pathway in high grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Robert E Brown; George Zotalis; Ping L Zhang; Bihong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.

Authors:  Laura E Pascal; Junkui Ai; Lora H Rigatti; Anne K Lipton; Wuhan Xiao; James R Gnarra; Zhou Wang
Journal:  Angiogenesis       Date:  2011-06-03       Impact factor: 9.596

8.  KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.

Authors:  Xinpei Ci; Changsheng Xing; Baotong Zhang; Zhiqian Zhang; Jenny Jianping Ni; Wei Zhou; Jin-Tang Dong
Journal:  Mol Cancer       Date:  2015-04-21       Impact factor: 27.401

9.  Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy.

Authors:  M I Koukourakis; A Giatromanolaki; M Panteliadou; S E Pouliliou; P S Chondrou; S Mavropoulou; E Sivridis
Journal:  Br J Cancer       Date:  2014-04-08       Impact factor: 7.640

10.  The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers.

Authors:  Weranja K B Ranasinghe; Lin Xiao; Suzana Kovac; Mike Chang; Carine Michiels; Damien Bolton; Arthur Shulkes; Graham S Baldwin; Oneel Patel
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.